These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 7969166

  • 21. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.
    Lu Q, Kamps MP.
    Oncogene; 1997 Jan 09; 14(1):75-83. PubMed ID: 9010234
    [Abstract] [Full Text] [Related]

  • 22. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
    Scheele JS, Kolanczyk M, Gantert M, Zemojtel T, Dorn A, Sykes DB, Möbest DC, Kamps MP, Räpple D.
    Leuk Lymphoma; 2009 May 09; 50(5):816-28. PubMed ID: 19399691
    [Abstract] [Full Text] [Related]

  • 23. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
    LeBrun DP, Matthews BP, Feldman BJ, Cleary ML.
    Oncogene; 1997 Oct 23; 15(17):2059-67. PubMed ID: 9366523
    [Abstract] [Full Text] [Related]

  • 24. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
    Sykes DB, Kamps MP.
    Mol Cell Biol; 2004 Feb 23; 24(3):1256-69. PubMed ID: 14729970
    [Abstract] [Full Text] [Related]

  • 25. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
    Knoepfler PS, Bergstrom DA, Uetsuki T, Dac-Korytko I, Sun YH, Wright WE, Tapscott SJ, Kamps MP.
    Nucleic Acids Res; 1999 Sep 15; 27(18):3752-61. PubMed ID: 10471746
    [Abstract] [Full Text] [Related]

  • 26. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
    Lin CH, Wang Z, Duque-Afonso J, Wong SH, Demeter J, Loktev AV, Somervaille TCP, Jackson PK, Cleary ML.
    Sci Rep; 2019 Mar 20; 9(1):4915. PubMed ID: 30894657
    [Abstract] [Full Text] [Related]

  • 27. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
    Diakos C, Xiao Y, Zheng S, Kager L, Dworzak M, Wiemels JL.
    PLoS One; 2014 Mar 20; 9(2):e87602. PubMed ID: 24503810
    [Abstract] [Full Text] [Related]

  • 28. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice.
    Feldman BJ, Hampton T, Cleary ML.
    Blood; 2000 Sep 01; 96(5):1906-13. PubMed ID: 10961893
    [Abstract] [Full Text] [Related]

  • 29. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP, Grasset MF, Mouchiroud G.
    Oncogene; 2007 Jan 11; 26(2):234-47. PubMed ID: 16819510
    [Abstract] [Full Text] [Related]

  • 30. Role for homodimerization in growth deregulation by E2a fusion proteins.
    Bayly R, LeBrun DP.
    Mol Cell Biol; 2000 Aug 11; 20(16):5789-96. PubMed ID: 10913162
    [Abstract] [Full Text] [Related]

  • 31. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
    Sera Y, Yamasaki N, Oda H, Nagamachi A, Wolff L, Inukai T, Inaba T, Honda H.
    Cancer Sci; 2016 Jul 11; 107(7):890-8. PubMed ID: 27088431
    [Abstract] [Full Text] [Related]

  • 32. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
    Holmlund T, Lindberg MJ, Grander D, Wallberg AE.
    Leukemia; 2013 Mar 11; 27(3):578-85. PubMed ID: 23044487
    [Abstract] [Full Text] [Related]

  • 33. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA.
    Abramovich C, Shen WF, Pineault N, Imren S, Montpetit B, Largman C, Humphries RK.
    J Biol Chem; 2000 Aug 25; 275(34):26172-7. PubMed ID: 10825160
    [Abstract] [Full Text] [Related]

  • 34. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation.
    Kamps MP.
    Curr Top Microbiol Immunol; 1997 Aug 25; 220():25-43. PubMed ID: 9103673
    [No Abstract] [Full Text] [Related]

  • 35. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP.
    Oncogene; 1999 Sep 02; 18(35):4920-9. PubMed ID: 10490826
    [Abstract] [Full Text] [Related]

  • 36. The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1.
    Knoepfler PS, Kamps MP.
    Mol Cell Biol; 1995 Oct 02; 15(10):5811-9. PubMed ID: 7565734
    [Abstract] [Full Text] [Related]

  • 37. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1.
    McWhirter JR, Goulding M, Weiner JA, Chun J, Murre C.
    Development; 1997 Sep 02; 124(17):3221-32. PubMed ID: 9310317
    [Abstract] [Full Text] [Related]

  • 38. Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2.
    van Dijk MA, Peltenburg LT, Murre C.
    Mech Dev; 1995 Jul 02; 52(1):99-108. PubMed ID: 7577680
    [Abstract] [Full Text] [Related]

  • 39. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1.
    Smith KS, Chanda SK, Lingbeek M, Ross DT, Botstein D, van Lohuizen M, Cleary ML.
    Mol Cell; 2003 Aug 02; 12(2):393-400. PubMed ID: 14536079
    [Abstract] [Full Text] [Related]

  • 40. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
    Lee YL, Ito K, Pi WC, Lin IH, Chu CS, Malik S, Cheng IH, Chen WY, Roeder RG.
    Proc Natl Acad Sci U S A; 2021 Feb 09; 118(6):. PubMed ID: 33542097
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.